| Literature DB >> 32528799 |
Chi Heon Kim1,2, Kirk Easley3, Jun-Seok Lee2,4, Jae-Young Hong2,5, Michael Virk6, Patrick C Hsieh7, Sangwook T Yoon2.
Abstract
STUDYEntities:
Keywords: lumbar interbody fusion; lumbosacral region; spine; transforaminal; vertebrae
Year: 2020 PMID: 32528799 PMCID: PMC7263326 DOI: 10.1177/2192568219882344
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Summary of Previous Studies.
| Author (year) | Study Type | Patient No. (MIS-TLIF vs Open-TLIF) | Short-term FU | Long-term FU (year) |
|---|---|---|---|---|
| Zhao (2019) | Prospective/RCT | 52 vs 4 | 7 Days, 1/3/6 months | 5 |
| Price (2018) | Prospective/Retrospective analysis | 148 vs 304 | 1 | |
| Wu (2017) | Prospective/Retrospective analysis | 47 vs 52 | 6 Months | 2 |
| Tian (2017) | Prospective/Retrospective analysis | 30 vs 31 | 3 Months | 2 |
| Serban (2017) | Prospective/RCT | 40 vs 40 | 1 | |
| Mummaneni (2017) | Prospective/As treated | 91 vs 254 | 1 | |
| Kulkarni (2016) | Prospective/As treated | 36 vs 25 | 3 | |
| Wong (2014) | Prospective/As treated | 144 vs 54 | 6 Months | 4 |
| Adogwa (2015) | Prospective/As treated | 40 vs 108 | 2 | |
| Singh (2014) | Prospective/RCT | 33 vs 33 | 6 Months | |
| Parker (2014) | Prospective/As treated | 50 vs 50 | 3 Months | 2 |
| Gu (2014) | Prospective/Quasi RCT (alternative day) | 44 vs 38 | 3 Days | 1 |
| Seng (2013) | Prospective/Retrospective matched control | 40 vs 40 | 6 Months | 5 |
| Rodriguez-Vela (2013) | Prospective/RCT | 20 vs 21 | 3 | |
| Parker (2012) | Prospective/As treated | 15 vs 15 | 2 | |
| Lee (2012) | Prospective/As treated | 72 vs 72 | 6 Months | 2 |
| Wang HL (2011) | Prospective/Quasi RCT (odd and even numbers) | 41 vs 38 | 3, 6 Months | 2 |
| Wang J (2010) | Prospective/As treated | 42 vs 43 | 3 Days | 2 |
| Shunwu (2010) | Prospective/As treated | 32 vs 30 | 6 Months | 2 |
| Peng (2009) | Prospective/Retrospective matched control | 29 vs 29 | 1 Day, 6 months | 2 |
Abbreviations: FU, follow-up period; RCT, randomized controlled trial; TLIF, transforaminal lumbar interbody fusion.
Figure 1.Forest plots for short-term clinical outcomes. Studies with available data of means and SDs are included in the graphs. The graph shows odds ratios and 95% CIs of each study. The pooled data show means and odds ratios of each parameter. A. Oswestry Disability Index. B. Visual Analogue Score for Back pain. C. Visual Analogue Score for Leg pain.
Abbreviations: MIS-TLIF, minimally invasive transforaminal interbody fusion; open TLIF, open transforaminal interbody fusion.
Figure 2.Forest plots for long-term clinical outcomes. Studies with more than 2-year follow-up periods are included in the analysis. Figure 1A showed the Oswestry Disability Index (ODI), Figure 1B showed Visual Analogue Score for Back pain (VAS-B), and 1C showed Visual Analogue Score for Leg pain (VAS-L). The graph shows odds ratios and 95% CIs of each study. The pooled data show means and odds ratios of each parameter. A. ODI. B. VAS-B. C. VAS-L.
Abbreviations: MIS-TLIF, minimally invasive transforaminal interbody fusion; open TLIF, open transforaminal interbody fusion.
Figure 3.Forest plot for spinal fusion. The graph shows event, number of patients, odds ratios (ORs) and 95% CIs of each study. The pooled data show that the OR of spinal fusion after open-TLIF was not statistically different from that for MIS-TLIF (OR, 0.86; 95% CI, 0.56-1.33).
Abbreviations: MIS-TLIF, minimally invasive transforaminal interbody fusion; open TLIF, open transforaminal interbody fusion.